Association of Lipoprotein Subfractions With Presence and Severity of Coronary Artery Disease in Patients Referred for Coronary Angiography.

[1]  Hongliang Cong,et al.  Lipoprotein Subfractions as Markers for Predicting the Presence and Severity of Coronary Artery Disease in Patients Undergoing Coronary Angiography , 2022, Angiology.

[2]  Theresa M. Beckie,et al.  2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2021, Journal of the American College of Cardiology.

[3]  A. Hovland,et al.  High-Density Lipoprotein Subfractions: Much Ado about Nothing or Clinically Important? , 2021, Biomedicines.

[4]  C. Kanonidou.  Small dense low-density lipoprotein: analytical review. , 2021, Clinica chimica acta; international journal of clinical chemistry.

[5]  L. Cupples,et al.  Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study , 2021, Journal of the American Heart Association.

[6]  S. Kaptoge,et al.  Association of small, dense LDL-cholesterol concentration and lipoprotein particle characteristics with coronary heart disease: A systematic review and meta-analysis , 2020, PloS one.

[7]  J. Ruidavets,et al.  Serum level of HDL particles are independently associated with long-term prognosis in patients with coronary artery disease: The GENES study , 2020, Scientific Reports.

[8]  N. Cook,et al.  Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease. , 2020, Journal of the American College of Cardiology.

[9]  T. Ninomiya,et al.  Small Dense Low-Density Lipoprotein Cholesterol and the Risk of Coronary Heart Disease in a Japanese Community , 2019, Journal of atherosclerosis and thrombosis.

[10]  Volkmar Falk,et al.  2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.

[11]  O. Melander,et al.  LDL subfractions are associated with incident cardiovascular disease in the Malmö Prevention Project Study. , 2017, Atherosclerosis.

[12]  M. Budoff,et al.  Association of Coronary Calcium, Carotid Wall Thickness, and Carotid Plaque Progression with Low Density Lipoprotein and High Density Lipoprotein Particle Concentration Measured by Ion Mobility (From Multiethnic Study of Atherosclerosis [MESA]). , 2017, The American journal of cardiology.

[13]  J. Otvos,et al.  Small and medium sized HDL particles are protectively associated with coronary calcification in a cross-sectional population-based sample. , 2016, Atherosclerosis.

[14]  M. Budoff,et al.  Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]). , 2016, The American journal of cardiology.

[15]  W. Kraus,et al.  High-density lipoprotein subclass measurements improve mortality risk prediction, discrimination and reclassification in a cardiac catheterization cohort. , 2016, Atherosclerosis.

[16]  J. Manson,et al.  Lipoprotein particles and size, total and high molecular weight adiponectin, and leptin in relation to incident coronary heart disease among severely obese postmenopausal women: The Women's Health Initiative Observational Study , 2015, BBA clinical.

[17]  E. Boerwinkle,et al.  Small Dense Low-Density Lipoprotein-Cholesterol Concentrations Predict Risk for Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[18]  W. Guan,et al.  New Automated Assay of Small Dense Low-Density Lipoprotein Cholesterol Identifies Risk of Coronary Heart Disease: The Multi-Ethnic Study of Atherosclerosis , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[19]  J. Backstrand,et al.  Low-density lipoprotein particle number predicts coronary artery calcification in asymptomatic adults at intermediate risk of cardiovascular disease. , 2011, Journal of clinical lipidology.

[20]  Samia Mora,et al.  Clinical implications of discordance between low-density lipoprotein cholesterol and particle number. , 2011, Journal of clinical lipidology.

[21]  Antonio Colombo,et al.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.

[22]  T. Katagiri,et al.  Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases. , 2006, Atherosclerosis.

[23]  T. Kang,et al.  Significance of Small Dense Low-Density Lipoprotein as a Risk Factor for Coronary Artery Disease and Acute Coronary Syndrome , 2006, Yonsei medical journal.

[24]  H. Bloomfield,et al.  Low-Density Lipoprotein and High-Density Lipoprotein Particle Subclasses Predict Coronary Events and Are Favorably Changed by Gemfibrozil Therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial , 2006, Circulation.

[25]  T. Katagiri,et al.  Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease. , 2002, American heart journal.

[26]  Alice Arnold,et al.  Nuclear Magnetic Resonance Spectroscopy of Lipoproteins and Risk of Coronary Heart Disease in the Cardiovascular Health Study , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[27]  Xiao-lin Li,et al.  High-density lipoprotein subfractions in relation with the severity of coronary artery disease: A Gensini score assessment. , 2015, Journal of clinical lipidology.

[28]  Christopher P Cannon,et al.  Acute coronary syndromes: diagnosis and management, part I. , 2009, Mayo Clinic proceedings.